These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23736844)

  • 1. Current world literature. Mineral metabolism. Renal pathophysiology.
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):488-501. PubMed ID: 23736844
    [No Abstract]   [Full Text] [Related]  

  • 2. Bibliography. Mineral metabolism. Current world literature.
    Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):433-7. PubMed ID: 21654392
    [No Abstract]   [Full Text] [Related]  

  • 3. Bibliography. Current world literature. Mineral metabolism.
    Curr Opin Nephrol Hypertens; 2000 Jul; 9(4):441-7. PubMed ID: 10926182
    [No Abstract]   [Full Text] [Related]  

  • 4. Bibliography. Current world literature. Mineral metabolism.
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):423-33. PubMed ID: 18660680
    [No Abstract]   [Full Text] [Related]  

  • 5. Bibliography. Current world literature. Mineral metabolism.
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):388-93. PubMed ID: 17565283
    [No Abstract]   [Full Text] [Related]  

  • 6. Bibliography. Renal pathophysiology. Current world literature.
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):454-61. PubMed ID: 22826837
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kidney and bone update : the 5-year history and future of CKD-MBD. Mineral and bone disorder in kidney transplant recipients].
    Fujii N; Okuno A; Yonemoto S; Nishimura K; Kishikawa H; Ichikawa Y
    Clin Calcium; 2012 Jul; 22(7):1050-8. PubMed ID: 22750938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bibliography. Current world literature. Mineral metabolism.
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):463-76. PubMed ID: 15309820
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular pathophysiology of renal calcium handling.
    Bindels RJ
    Kidney Blood Press Res; 2000; 23(3-5):183-4. PubMed ID: 11031716
    [No Abstract]   [Full Text] [Related]  

  • 10. Current world literature.
    Curr Opin Nephrol Hypertens; 2009 Jul; 18(4):363-77. PubMed ID: 19542981
    [No Abstract]   [Full Text] [Related]  

  • 11. Bibliography. Current world literature. Renal pathophysiology.
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):467-71. PubMed ID: 16869063
    [No Abstract]   [Full Text] [Related]  

  • 12. Mineral and bone metabolism in dialysis: towards unified patient care?
    Pelletier S; Fouque D
    Nephrol Dial Transplant; 2011 Jan; 26(1):7-9. PubMed ID: 21106773
    [No Abstract]   [Full Text] [Related]  

  • 13. [From renal osteodistrophy to bone and mineral metabolism lesions associated to renal chronic disease].
    Lorenzo V; Rodríguez Portillo M; Pérez García R; Cannata JB
    Nefrologia; 2007; 27(5):527-33. PubMed ID: 18045027
    [No Abstract]   [Full Text] [Related]  

  • 14. FGF23 and mineral metabolism, implications in CKD-MBD.
    Rodríguez M; López I; Muñoz J; Aguilera-Tejero E; Almaden Y
    Nefrologia; 2012 May; 32(3):275-8. PubMed ID: 22592418
    [No Abstract]   [Full Text] [Related]  

  • 15. [Foreword. Brazilian clinical practice guidelines for mineral and bone disorders in chronic renal disease].
    de Carvalho AB
    J Bras Nefrol; 2011; 33(2):191. PubMed ID: 21789443
    [No Abstract]   [Full Text] [Related]  

  • 16. Mineral metabolism: confusion to clarity.
    Bushinsky DA; Wolf MS
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):353-4. PubMed ID: 22622652
    [No Abstract]   [Full Text] [Related]  

  • 17. Mineral metabolism: new aspects and perspectives.
    Drüeke TB
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):297-9. PubMed ID: 8823525
    [No Abstract]   [Full Text] [Related]  

  • 18. [Management of mineral and bone disease caused by chronic renal disease: what recommendations have contributed].
    Houillier P;
    Nephrol Ther; 2008 Sep; 4 Spec No 1():2-8, 15-9. PubMed ID: 19031626
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications.
    Damasiewicz MJ; Toussaint ND; Polkinghorne KR
    Nephrology (Carlton); 2011 Mar; 16(3):261-8. PubMed ID: 21265930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineral and bone disorder and outcomes in hemodialysis patients: results from the DOPPS.
    Tentori F
    Semin Dial; 2010; 23(1):10-4. PubMed ID: 20331811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.